Vertex Pharmaceuticals Thursday appointed Matthew Emmens president, with an expected transition to CEO and chairman in May 2009, when current CEO Joshua Boger is set to retire.
Emmens, a 35-year pharma industry veteran, has been a Vertex director since 2004. He previously served as CEO of Shire plc and Astra Merck Inc., and as president for [...]
PharmExec Blog
Follow Us
RSS
Bookstore
Vertex Names Emmens President, Future CEO